Physician
Infectious Disease
Dr. Donald R. Skillman, MD
|
|
Give Review
Dr. Donald R. Skillman works in the field of Infectious Disease. He researched medicine at Uniformed Services University of the Health Sciences. Uniformed Services University of the Health Sciences has a rank of 72 in research and a 47 in primary care He received 1 awards: "Meaningful Use Stage 1 Certification". Donald Skillman has written publications. He has 20 publications published with PubMed. The lastest paper is: 'Neuropsychological effects of Interferon Alfa-n3 treatment in asymptomatic human immunodeficiency virus-1-infected individuals.' Dr. Donald R. Skillman is registered with Medicare.
Publications
- Role of specific cytochrome P450 isoforms in the conversion of phenoxypropoxybiguanide analogs in human liver microsomes to potent antimalarial dihydrotriazines.
- Pharmacokinetics, safety, and hydrolysis of oral pyrroloquinazolinediamines administered in single and multiple doses in rats.
- Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.
- In vitro metabolism of phenoxypropoxybiguanide analogues in human liver microsomes to potent antimalarial dihydrotriazines.
- The medicinal chemistry of botulinum, ricin and anthrax toxins.
- Structure identification and prophylactic antimalarial efficacy of 2-guanidinoimidazolidinedione derivatives.
- Acquired immunodeficiency syndrome-related blastomycosis in an unusual geographic location.
- Norwalk-like viral gastroenteritis outbreak in U.S. Army trainees.
- Sialylation lessens the infectivity of Neisseria gonorrhoeae MS11mkC.
- Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity.
- Neuropsychological effects of Interferon Alfa-n3 treatment in asymptomatic human immunodeficiency virus-1-infected individuals.
- Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis.
- Increased efficacy of human natural interferon alpha (IFN-alpha n3) versus human recombinant IFN-alpha 2 for inhibition of HIV-1 replication in primary human monocytes.
- Interferon alpha (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: role of IFN in the tempo and progression of HIV disease.
- Macrophages and the human immunodeficiency virus.
- Macrophage-HIV interaction: viral isolation and target cell tropism.
- Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.
- HIV infection and the acquired immunodeficiency syndrome: a strategy for public education.
- Spectinomycin and cholestatic jaundice.
Schools
Uniformed Services University of The Health Sciences
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Tripler Army Medical Center -
Madigan Healthcare System -
Uniformed Services University of the Health Sciences
Drug Facts
| NPI NUMBER | 1114915360 | |
| NPPES Provider LastName | SKILLMAN | |
| NPPES Provider FirstName | DONALD | |
| NPPES Provider ZIPCode | 209107500 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 7424.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 355.0 | |
| Percent Opioid Claims | 4.78 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114915360 |
| Last Name Of The Provider | SKILLMAN |
| First Name Of The Provider | DONALD |
| View All |
Similar Doctors
|
|
Dr. Anne M. Anglim, MD
 This Doctor is OpenDoctor Recommended.
|